Invitae Corporation
NVTA
Rankning i aktier
#35760
Invitae Corporation operates as a medical genetics enterprise, striving to... Invitae Corporation operates as a medical genetics enterprise, striving to integrate genetic insights into mainstream medical practice to enhance healthcare outcomes for individuals in the United States, Canada, and internationally. The company provides a comprehensive suite of offerings, including genetic testing for various clinical specializations such as hereditary cancer, cardiovascular health, neurological disorders, pediatric conditions, oncology, metabolic ailments, and rare diseases, alongside digital health tools and health data services. Its clientele spans individual patients, healthcare providers, biopharmaceutical firms, and other collaborators. Established in 2010 as Locus Development, Inc., the company officially became Invitae Corporation in 2012 and is headquartered in San Francisco, California.
Aktiekurs
$0.016
Senast synkroniserad: 2024-03-11
Marknadsvärde
$3.27M
Förändring (1 dag)
-5.33%
Förändring (1 år)
5,233.33%
Land
US
Handel Invitae Corporation (NVTA)
Kategori
Healthcare
Historik för aktiesplit för Invitae Corporation (NVTA)
Aktien Invitae Corporation (symbol: NVTA) har genomgått totalt 0 aktiesplitar.
Den senaste spliten skedde den Oct 21, 2026.
En NVTA-aktie köpt före Oct 21, 2026 motsvarar nu 0 NVTA-aktier.
Den senaste spliten skedde den Oct 21, 2026.
En NVTA-aktie köpt före Oct 21, 2026 motsvarar nu 0 NVTA-aktier.
Lista över aktiesplitar
| År | Split | Multipel | Kumulativ multipel |
|---|---|---|---|
| Inte tillräckligt med data för de angivna datumen. | |||
Aktiesplitar för liknande företag eller konkurrenter
| Företag | Antal aktiesplitar | Kumulativ multipel | Land |
|---|---|---|---|
| 8 | x34 |
US
|
|
| 7 | x47 |
US
|
|
| 0 | - |
US
|
|
| 0 | - |
CN
|
|
| 1 | x1 |
US
|
